Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DICE

DICE Therapeutics (DICE) Stock Price, News & Analysis

DICE Therapeutics logo

About DICE Therapeutics Stock (NASDAQ:DICE)

Key Stats

Today's Range
$47.55
$47.55
50-Day Range
$46.62
$47.55
52-Week Range
$15.08
$47.90
Volume
N/A
Average Volume
1.03 million shs
Market Capitalization
$2.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DICE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DICE Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DICE Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
Buy, Sell, Or Hold LLY Stock At $850?
See More Headlines

DICE Stock Analysis - Frequently Asked Questions

DICE Therapeutics, Inc. (NASDAQ:DICE) announced its quarterly earnings data on Friday, November, 12th. The company reported ($2.30) EPS for the quarter, missing analysts' consensus estimates of ($0.53) by $1.77.

DICE Therapeutics (DICE) raised $160 million in an initial public offering on Wednesday, September 15th 2021. The company issued 10,000,000 shares at $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that DICE Therapeutics investors own include Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX), Honeywell International (HON), HubSpot (HUBS), Walt Disney (DIS) and Bank of America (BAC).

Company Calendar

Last Earnings
11/12/2021
Today
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:DICE
CIK
1645569
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.89 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-22.01%
Return on Assets
-20.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
25.88
Quick Ratio
32.44

Sales & Book Value

Annual Sales
$1.13 million
Price / Sales
2,008.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.86 per share
Price / Book
4.38

Miscellaneous

Outstanding Shares
47,731,000
Free Float
45,392,000
Market Cap
$2.27 billion
Optionable
Not Optionable
Beta
1.03

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:DICE) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners